Location History:
- München, DE (2007)
- Planegg-Martinsried, DE (2013 - 2020)
Company Filing History:
Years Active: 2007-2020
Title: Roland Baumgartner: Innovator in Cancer Treatment
Introduction
Roland Baumgartner is a notable inventor based in Planegg-Martinsried, Germany. He has made significant contributions to the field of cancer treatment through his innovative research and development. With a total of 5 patents, Baumgartner's work focuses on advancing medical therapies that target specific pathways involved in cancer progression.
Latest Patents
One of Baumgartner's latest patents is a method of inhibiting DYRK1B. This invention relates to a DYRK1B inhibitor for use in the treatment of cancer, particularly in cases where the hedgehog signaling pathway is activated. Notably, this activation occurs independently of signaling by the G protein-coupled receptor Smoothened. This innovative approach has the potential to provide new avenues for cancer therapy.
Career Highlights
Throughout his career, Baumgartner has worked with several prominent companies, including 4SC AG and 4SC Discovery GmbH. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Baumgartner has collaborated with notable colleagues such as Johann Leban and Daniel Vitt. These partnerships have further enhanced his research capabilities and have been instrumental in the development of his patented technologies.
Conclusion
Roland Baumgartner's innovative work in cancer treatment exemplifies the impact of dedicated research and development in the medical field. His contributions continue to pave the way for advancements in therapeutic strategies against cancer.